Literature DB >> 7661873

Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination.

H T Vanhanen1, T A Miettinen.   

Abstract

The study evaluates cholesterol metabolism off and on treatment with pravastatin (P), gemfibrozil (G) and their combination (PG) in 38 middle-age hyperlipidemic primary care patients with serum cholesterol > 6 mmol/l and serum triglycerides < 4 mmol/l after a low-fat low-cholesterol diet. The subjects were randomized to P (40 mg/g), G (1200 mg/day), PG (40 + 1200 mg/day) or placebo for 12 weeks. We analyzed serum lipids, apolipoproteins A-I, B and E, serum cholesterol precursors (markers of cholesterol synthesis), serum plant sterols and cholestanol (markers of cholesterol absorption) and cholesterol metabolism by the sterol balance technique and cholesterol absorption efficiency. P alone or in combination with G lowered apoprotein E concentration, and serum cholesterol levels by inhibiting cholesterol synthesis measured by the precursor/cholesterol proportions with inconsistent change in fecal output of cholesterol. G alone decreased bile acid synthesis and increased biliary cholesterol secretion which were associated with reduced cholesterol absorption efficiency and the serum plant sterol and cholestanol proportions, and increased synthesis of cholesterol as measured both by the sterol balance technique and the precursor sterol proportions. A combination of PG also lowered LDL cholesterol similarly but triglyceride-rich lipoproteins significantly more than P alone, and otherwise inhibited the changes caused by G in cholesterol metabolism except that the precursor sterol proportions still indicated reduced cholesterol synthesis. Overall, the changes of the cholesterol precursor proportions were negatively related to that of cholesterol absorption efficiency and positively to that of cholesterol synthesis. The respective plant sterol and cholestanol values correlated oppositely to cholesterol absorption efficiency and synthesis. Serum precursor sterols reflected changes in cholesterol synthesis more sensitively than the sterol balance technique, even though only the latter method can quantitate cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661873     DOI: 10.1016/0021-9150(94)05474-w

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

Review 1.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

2.  Statins increase hepatic cholesterol synthesis and stimulate fecal cholesterol elimination in mice.

Authors:  Marleen Schonewille; Jan Freark de Boer; Laura Mele; Henk Wolters; Vincent W Bloks; Justina C Wolters; Jan A Kuivenhoven; Uwe J F Tietge; Gemma Brufau; Albert K Groen
Journal:  J Lipid Res       Date:  2016-06-16       Impact factor: 5.922

Review 3.  Cholesterol absorption: influence of body weight and the role of plant sterols.

Authors:  Helena Gylling; Tatu A Miettinen
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

Review 4.  Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.

Authors:  Lin Jia; Jenna L Betters; Liqing Yu
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

5.  Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers.

Authors:  Thomas M van Himbergen; Nirupa R Matthan; Nancy A Resteghini; Seiko Otokozawa; Masumi Ai; Evan A Stein; Peter H Jones; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2008-11-30       Impact factor: 5.922

Review 6.  Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.

Authors:  C M Spencer; L B Barradell
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.